190 related articles for article (PubMed ID: 28929029)
1. Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and
Khalid S; Hanif R
PeerJ; 2017; 5():e3822. PubMed ID: 28929029
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
[TBL] [Abstract][Full Text] [Related]
3. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
4. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
5. CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.
de Oliveira KB; Guembarovski RL; Guembarovski AM; da Silva do Amaral Herrera AC; Sobrinho WJ; Ariza CB; Watanabe MA
Clin Exp Med; 2013 Aug; 13(3):211-9. PubMed ID: 22699677
[TBL] [Abstract][Full Text] [Related]
6. CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.
Okuyama NCM; Cezar-Dos-Santos F; Trugilo KP; Esposito A; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
J Cancer Res Clin Oncol; 2022 Apr; 148(4):793-802. PubMed ID: 35083551
[TBL] [Abstract][Full Text] [Related]
7. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.
Lin GT; Tseng HF; Yang CH; Hou MF; Chuang LY; Tai HT; Tai MH; Cheng YH; Wen CH; Liu CS; Huang CJ; Wang CL; Chang HW
OMICS; 2009 Apr; 13(2):165-72. PubMed ID: 19196101
[TBL] [Abstract][Full Text] [Related]
8. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV
Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386
[TBL] [Abstract][Full Text] [Related]
9. Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.
Alijanpour A; Golshan A; Vakili-Ojarood M; Shirinzadeh-Dastgiri A; Naseri A; Karimi-Zarchi M; Hajizadeh N; Barahman M; Azizi S; Aghasipour M; Khajehnoori S; Aghili K; Neamatzadeh H
Asian Pac J Cancer Prev; 2024 Mar; 25(3):767-776. PubMed ID: 38546059
[TBL] [Abstract][Full Text] [Related]
10. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma.
Chen R; Xu Y; Du X; Liu N; Li Y; He Q; Tang L; Mao Y; Sun Y; Chen L; Ma J
Onco Targets Ther; 2015; 8():2835-42. PubMed ID: 26504400
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor susceptibility: possible involvement of FOXP3 and CXCL12 genes.
Ozawa PM; Ariza CB; Losi-Guembarovski R; Guembarovski AL; de Oliveira CE; Banin-Hirata BK; Kishima MO; Petenuci DL; Watanabe MA
Mol Cell Pediatr; 2016 Dec; 3(1):36. PubMed ID: 27830498
[TBL] [Abstract][Full Text] [Related]
14. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.
Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K
Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392
[TBL] [Abstract][Full Text] [Related]
15. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
[TBL] [Abstract][Full Text] [Related]
16. The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis.
Xu K; Dai H; Wang S; Zhang J; Liu T
Onco Targets Ther; 2018; 11():2445-2452. PubMed ID: 29760554
[TBL] [Abstract][Full Text] [Related]
17. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
[TBL] [Abstract][Full Text] [Related]
18. SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancer.
Schimanski CC; Jordan M; Schlaegel F; Schmidtmann I; Lang H; Galle PR; Moehler M; Gockel I
Int J Oncol; 2011 Aug; 39(2):515-20. PubMed ID: 21584490
[TBL] [Abstract][Full Text] [Related]
19. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.
Kruszyna Ł; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
DNA Cell Biol; 2010 Aug; 29(8):423-7. PubMed ID: 20406099
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues.
Allami RH; Graf C; Martchenko K; Voss B; Becker M; Berger MR; Galle PR; Theobald M; Wehler TC; Schimanski CC
Oncol Lett; 2016 Mar; 11(3):1873-1878. PubMed ID: 26998092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
